C41 -Malignant neoplasm of bone and articular cartilage of other and unspecified sites
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C41 – N =1,106
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 23.4% | 10.9% | 0% | 15.6% | 50% | 64 |
1996 | 20% | 13.3% | 1.7% | 18.3% | 46.7% | 60 |
1997 | 24.6% | 12.3% | 0% | 12.3% | 50.8% | 65 |
1998 | 19% | 0% | 2.4% | 19% | 59.5% | 42 |
1999 | 18.4% | 10.2% | 2% | 16.3% | 53.1% | 49 |
2000 | 22.2% | 14.8% | 5.6% | 20.4% | 37% | 54 |
2001 | 11.3% | 11.3% | 0% | 22.6% | 54.8% | 62 |
2002 | 8.7% | 6.5% | 4.3% | 17.4% | 63% | 46 |
2003 | 9.1% | 12.7% | 0% | 25.5% | 52.7% | 55 |
2004 | 18.5% | 16.9% | 4.6% | 13.8% | 46.2% | 65 |
2005 | 15.4% | 12.3% | 3.1% | 4.6% | 64.6% | 65 |
2006 | 16.1% | 14.3% | 5.4% | 14.3% | 50% | 56 |
2007 | 12.1% | 19% | 3.4% | 19% | 46.6% | 58 |
2008 | 13.3% | 10% | 3.3% | 25% | 48.3% | 60 |
2009 | 13% | 5.6% | 3.7% | 38.9% | 38.9% | 54 |
2010 | 22.7% | 13.6% | 2.3% | 29.5% | 31.8% | 44 |
2011 | 20.4% | 8.2% | 0% | 12.2% | 59.2% | 49 |
2012 | 19.4% | 8.1% | 0% | 25.8% | 46.8% | 62 |
2013 | 13.2% | 9.4% | 0% | 18.9% | 58.5% | 53 |
2014 | 20.9% | 14% | 2.3% | 20.9% | 41.9% | 43 |